Average Co-Inventor Count = 6.48
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (10 from 2,405 patents)
2. Schering Corporation (6 from 1,829 patents)
3. Mochida Pharmaceutical Co., Ltd. (1 from 227 patents)
4. Merck Canada Inc. (1 from 40 patents)
5. Msd Italia S.r.l. (1 from 7 patents)
16 patents:
1. 11161819 - Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists
2. 9708270 - Substituted spiropiperidinyl compounds useful as GPR120 agonists
3. 9328138 - HCV NS3 protease inhibitors
4. 8987195 - HCV NS3 protease inhibitors
5. 8987242 - Morpholinone compounds as factor IXA inhibitors
6. 8604195 - Substituted bicyclic piperidinyl- and piperazinyl-sulfonamides useful to inhibit 11β-hydroxysteroid dehydrogenase type-1
7. 8580807 - Bicyclic piperidine and piperazine derivatives as GPCR modulators for the treatment of obesity, diabetes and other metabolic disorders
8. 8466149 - 6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11β-hydroxysteroid dehydrogenase type-I
9. 8389532 - 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-E]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amine
10. 8318751 - Pyrimidinone derivatives and methods of use thereof
11. 7709492 - [object Object]
12. 7572802 - 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amine
13. 7465740 - 2-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
14. 7368449 - [object Object]
15. 6916811 - Adenosine A2a receptor antagonists